270 related articles for article (PubMed ID: 19934399)
1. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
[TBL] [Abstract][Full Text] [Related]
2. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O
J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493
[TBL] [Abstract][Full Text] [Related]
3. Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
Koeberle A; Zettl H; Greiner C; Wurglics M; Schubert-Zsilavecz M; Werz O
J Med Chem; 2008 Dec; 51(24):8068-76. PubMed ID: 19053751
[TBL] [Abstract][Full Text] [Related]
4. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
[TBL] [Abstract][Full Text] [Related]
5. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
[TBL] [Abstract][Full Text] [Related]
6. Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol.
Koeberle A; Northoff H; Werz O
Biochem Pharmacol; 2009 May; 77(9):1513-21. PubMed ID: 19426689
[TBL] [Abstract][Full Text] [Related]
7. Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1.
Koeberle A; Haberl EM; Rossi A; Pergola C; Dehm F; Northoff H; Troschuetz R; Sautebin L; Werz O
Bioorg Med Chem; 2009 Dec; 17(23):7924-32. PubMed ID: 19884011
[TBL] [Abstract][Full Text] [Related]
8. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
[TBL] [Abstract][Full Text] [Related]
9. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Pollastro F; Northoff H; Werz O
Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
[TBL] [Abstract][Full Text] [Related]
10. Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo.
Bauer J; Koeberle A; Dehm F; Pollastro F; Appendino G; Northoff H; Rossi A; Sautebin L; Werz O
Biochem Pharmacol; 2011 Jan; 81(2):259-68. PubMed ID: 20933508
[TBL] [Abstract][Full Text] [Related]
11. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
12. Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1.
Koeberle A; Bauer J; Verhoff M; Hoffmann M; Northoff H; Werz O
Biochem Biophys Res Commun; 2009 Oct; 388(2):350-4. PubMed ID: 19665000
[TBL] [Abstract][Full Text] [Related]
13. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.
Koeberle A; Siemoneit U; Bühring U; Northoff H; Laufer S; Albrecht W; Werz O
J Pharmacol Exp Ther; 2008 Sep; 326(3):975-82. PubMed ID: 18550688
[TBL] [Abstract][Full Text] [Related]
14. Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.
Hieke M; Greiner C; Dittrich M; Reisen F; Schneider G; Schubert-Zsilavecz M; Werz O
J Med Chem; 2011 Jul; 54(13):4490-507. PubMed ID: 21591611
[TBL] [Abstract][Full Text] [Related]
15. Structure-based discovery of inhibitors of microsomal prostaglandin E2 synthase-1, 5-lipoxygenase and 5-lipoxygenase-activating protein: promising hits for the development of new anti-inflammatory agents.
De Simone R; Chini MG; Bruno I; Riccio R; Mueller D; Werz O; Bifulco G
J Med Chem; 2011 Mar; 54(6):1565-75. PubMed ID: 21323313
[TBL] [Abstract][Full Text] [Related]
16. Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase-1.
Bauer J; Kuehnl S; Rollinger JM; Scherer O; Northoff H; Stuppner H; Werz O; Koeberle A
J Pharmacol Exp Ther; 2012 Jul; 342(1):169-76. PubMed ID: 22511203
[TBL] [Abstract][Full Text] [Related]
17. Hyperforin, an Anti-Inflammatory Constituent from St. John's Wort, Inhibits Microsomal Prostaglandin E(2) Synthase-1 and Suppresses Prostaglandin E(2) Formation in vivo.
Koeberle A; Rossi A; Bauer J; Dehm F; Verotta L; Northoff H; Sautebin L; Werz O
Front Pharmacol; 2011; 2():7. PubMed ID: 21687502
[TBL] [Abstract][Full Text] [Related]
18. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways.
Moon Y; Glasgow WC; Eling TE
J Pharmacol Exp Ther; 2005 Nov; 315(2):788-95. PubMed ID: 16081677
[TBL] [Abstract][Full Text] [Related]
19. A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.
Hieke M; Greiner C; Thieme TM; Schubert-Zsilavecz M; Werz O; Zettl H
Bioorg Med Chem Lett; 2011 Mar; 21(5):1329-33. PubMed ID: 21310608
[TBL] [Abstract][Full Text] [Related]
20. Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibition.
Hanke T; Lamers C; Gomez RC; Schneider G; Werz O; Schubert-Zsilavecz M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3757-63. PubMed ID: 25037914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
